Publications

The latest list of publications available on PubMed.
ORCID ID: 0000-0002-6543-2774

  1. Pino E, Zuo Y, Olivera CM, Borba CPC, Henderson DC, Kalesan B. Clinical depression and anxiety among ST-elevation myocardial infarction hospitalizations: Results from Nationwide Inpatient Sample 2004-2013. Psychiatry Research PMID: 29615266
  2. Pino E, Zuo Y, Olivera CM, Keiser O, Moore LL, Li F, Ramachandran VS, Corkey BE, Kalesan B. Cohort Profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) Consortium. BMJ Open (in press)
  3. Mustafa J, Ellison RC, Singer MR, Bradlee ML, Kalesan B, Holick MF, Moore LL. Dietary Protein and Preservation of Physical Functioning Among Middle-aged and Older Adults in the Framingham Offspring Study. PMCID: 29590270
  4. Kalesan B, Cheng TW, Farber A, Zuo Y, Kalish JA, Jones DW, Siracuse JJ. Readmissions after thoracic endovascular aortic repair. J Vasc Surg. 2018 Mar 2. pii: S0741-5214(18)30138-1. PMID: 29506946
  5. Zuo Y, Pino EC, Vyliparambil M, Kalesan B. Sex Differences in Early Cardiovascular and All-Cause Hospitalization Outcomes After Surviving Firearm Injury. Am J Mens Health. 2018 Mar 1:1557988318761989. PMID: 29540125
  6. Kalesan B, Zuo Y, Xuan Z, Siegel MB, Fagan J, Branas C, Galea S. A multi-decadal Joinpoint analysis of firearm injury severity. Trauma Surg Acute Care Open 2018;3:1-7.
  7. Pino EC, Damus K, Jack B, Henderson D, Milanovic S, Kalesan B. Adolescent socioeconomic status and depressive symptoms in later life: Evidence from structural equation models. J Affect Disord. 2018 Jan 1;225:702-708. PMID: 28917197.
  8. Díez C, Kurland RP, Rothman EF, Bair-Merritt M, Fleegler E, Xuan Z, Galea S, Ross CS, Kalesan B, Goss KA, Siegel M. State Intimate Partner Violence-Related Firearm Laws and Intimate Partner Homicide Rates in the United States, 1991 to 2015. Ann Intern Med. 2017 Oct 17; 167(8): 536-543. PMID: 28975202.
  9. Kalesan B, Galea S, Fagan JA. Three Authors reply. Am J Epidemiol. 2017 Oct 1;186(7): 897-898. PMID: 28978196.
  10. Siegel M, Xuan Z, Ross CS, Galea S, Kalesan B, Fleegler E, Goss KA. Easiness of Legal Access to Concealed Firearm Permits and Homicide Rates in the United States. Am J Public Health. 2017 Dec;107(12):1923-1929. PMID: 29048964.
  11. Smith VM, Siegel M, Xuan Z, Ross CS, Galea S, Kalesan B, Fleegler E and Goss KA. Broadening the Perspective on Gun Violence: An Examination of the Firearms Industry, 1990-2015. Am J Prev Med. 2017. PMID: 28648260.
  12. Kalesan B, Galea S. Patterns of gun deaths across US counties 1999-2013. Ann Epidemiol. 2017 May;27(5):302-307. PMID: 28528742.
  13. Siegel M, Pahn M, Xuan Z, Ross CS, Galea S, Kalesan B, Fleegler E, Goss KA. Firearm-Related Laws in All 50 US States, 1991-2016. Am J Public Health. 2017 Jul;107(7):1122-1129. PMID: 28520491.
  14. Chimbetete C, Mugglin C, Shamu T, Kalesan B, Bertisch B, Egger M, Keiser O. New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis. Trop Med Int Health. 2017 Jul;22(7):839-845. PMID: 28510998.
  15. Kalesan B. The Cost of Firearm Violence Survivorship. Am J Public Health. 2017May;107(5):638-639. PMID: 28398796.
  16. Niiranen TJ, Kalesan B, Larson MG, Hamburg NM, Benjamin EJ, Mitchell GF, Vasan RS. Aortic-Brachial Arterial Stiffness Gradient and Cardiovascular Risk in the Community: The Framingham Heart Study. Hypertension. 2017 Jun;69(6):1022-1028. PMID: 28396534.
  17. Kalesan B, Adhikarla C, Pressley JC, Fagan JA, Xuan Z, Siegel MB, Galea S. The Hidden Epidemic of Firearm Injury: Increasing Firearm Injury Rates During 2001-2013. Am J Epidemiol. 2017 Apr 1;185(7):546-553. PMID: 28338922.
  18. Kalesan B, Lagast K, Villarreal M, Pino E, Fagan J, Galea S. School shootings during 2013-2015 in the USA. Inj Prev. 2016 Dec 6. pii: injuryprev-2016-042162. PMID: 27923800.
  19. Niiranen TJ, Kalesan B, Hamburg NM, Benjamin EJ, Mitchell GF, Vasan RS. Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study. J Am Heart Assoc. 2016 Oct 26;5(11). pii:e004271. PMID: 27912210.
  20. Kalesan B, Weinberg J, Galea S. Gun violence in Americans’ social network during their lifetime. Prev Med. 2016 Dec;93:53-56. PubMed PMID: 27667339.
  21. Kalesan B, Fagan J, Galea S. Gun violence prevention – Authors’ reply. Lancet. 2016 Jul 16;388(10041):234. PMID: 27479565.
  22. Kalesan B, Mobily ME, Keiser O, Fagan JA, Galea S. Firearm legislation and firearm mortality in the USA: a cross-sectional, state-level study. Lancet. 2016 Apr 30;387(10030):1847-55. PMID: 26972843.
  23. Kalesan B, Mobily ME, Vasan S, Siegel M, Galea S. The Role of Interpersonal Conflict as a Determinant of Firearm-Related Homicide-Suicides at Different Ages. J Interpers Violence. 2016 Feb 3. pii: 0886260516629387. PMID: 26843182.
  24. Kalesan B, Dabic S, Vasan S, Stylianos S, Galea S. Racial/Ethnic Specific Trends in Pediatric Firearm-Related Hospitalizations in the United States, 1998-2011. Matern Child Health J. 2016 May;20(5):1082-90. PMID: 26645619.
  25. Kalesan B, Vyliparambil MA, Bogue E, Villarreal MD, Vasan S, Fagan J, DiMaggio CJ, Stylianos S, Galea S; Firearm Injury Research Group. Race and ethnicity, neighborhood poverty and pediatric firearm hospitalizations in the United States. Ann Epidemiol. 2016 Jan;26(1):1-6.e1-2. PMID: 26596958.
  26. Korner EJ, Morris A, Allen IE, Hurvitz S, Beattie MS, Kalesan B. NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer. Syst Rev. 2015 Oct 1;4:133. PMID: 26428301.
  27. Truby L, Mundy L, Kalesan B, Kirtane A, Colombo PC, Takeda K, Fukuhara S, Naka Y, Takayama H. Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center. ASAIO J. 2015 Jul-Aug;61(4):403-9. PMID: 26125665.
  28. Kalesan B, Villarreal MD, Keyes KM, Galea S. Gun ownership and social gun culture. Inj Prev. 2016 Jun;22(3):216-20. doi: 10.1136/injuryprev-2015-041586. Epub 2015 Jun 29. PubMed PMID: 26124073; PubMed Central PMCID: PMC4809774.
  29. Ramaswami R, Villarreal MD, Pitta DM, Carpenter JS, Stebbing J, Kalesan B. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015 Jul;152(2):231-7. PMID: 26067931.
  30. Blaser N, Vizcaya LS, Estill J, Zahnd C, Kalesan B, Egger M, Gsponer T, Keiser O. gems: An R Package for Simulating from Disease Progression Models. J Stat Softw. 2015 Mar;64(10):1-22. PMID: 26064082.
  31. Kalesan B, Galea S. The relation of depression to in-hospital outcomes among adults hospitalized for firearm-related injury. J Affect Disord. 2015 Sep 1;183:166-72. PMID:26021965.
  32. Dionizovik-Dimanovski M, Levin AP, Fried J, Mody KP, Simonich E, Garan AR, Yuzefpolskaya M, Takayama H, Naka Y, Colombo PC, Kalesan B, Uriel N, Jorde UP. Correlation Between Home INR and Core Laboratory INR in Patients Supported with Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2015 Jul-Aug;61(4):386-90. PMID: 25905496.
  33. George I, Nazif TM, Kalesan B, Kriegel J, Yerebakan H, Kirtane A, Kodali SK, Williams MR. Feasibility and Early Safety of Single-Stage Hybrid Coronary Intervention and Valvular Cardiac Surgery. Ann Thorac Surg. 2015 Jun;99(6):2032-7. PMID: 25865767.
  34. Pilgrim T, Rothenbühler M, Kalesan B, Pulver C, Stefanini GG, Zanchin T, Räber L, Stortecky S, Jung S, Mattle H, Moschovitis A, Wenaweser P, Meier B, Gsponer T, Windecker S, Jüni P. Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. PLoS One. 2014 Dec 9;9(12):e114846. PMID: 25489846.
  35. Truby L, Naka Y, Kalesan B, Ota T, Kirtane AJ, Kodali S, Nikic N, Mundy L, Colombo P, Jorde UP, Takayama H. Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. Eur J Cardiothorac Surg. 2015 Aug;48(2):322-8. PMID: 25480935.
  36. Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Yuzefpolskaya M, Mancini DM, Naka Y. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2015 Jan;34(1):89-99. PMID: 25444372.
  37. Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Naka Y. Long-term outcome of patients on continuous-flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1606-14. PMID: 25260275.
  38. Kalesan B, Vasan S, Mobily ME, Villarreal MD, Hlavacek P, Teperman S, Fagan JA, Galea S. State-specific, racial and ethnic heterogeneity in trends of firearm-related fatality rates in the USA from 2000 to 2010. BMJ Open. 2014 Aug 14;4(9):e005628. PMID: 25239291
  39. Stefanini GG, Taniwaki M, Kalesan B, Räber L, Stortecky S, Pilgrim T, Onuma Y, Silber S, Serruys PW, Meier B, Jüni P, Windecker S. The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One. 2014 Sep 3;9(9):e106450. PMID: 25184244
  40. Khalique OK, Hahn RT, Gada H, Nazif TM, Vahl TP, George I, Kalesan B, Forster M, Williams MB, Leon MB, Einstein AJ, Pulerwitz TC, Pearson GD, Kodali SK. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014 Aug;7(8):885-94. PMID:25147034.
  41. Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, Khalpey Z, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014 Sep;7(5):799-806. PubMed PMID: 25027874; PubMed Central PMCID: PMC4369383.
  42. George I, Kriegel J, Nazif T, Kalesan B, Paradis JM, Khalique O, Hahn RT, Leon MB, Kodali S, Williams MR. Transthoracic access for transcatheter aortic valve replacement: technique using the Edwards Sapien Retroflex delivery system. Ann Thorac Surg. 2014 Jul;98(1):347-9. PMID: 24996727.
  43. Räber L, Zanchin T, Baumgartner S, Taniwaki M, Kalesan B, Moschovitis A, Garcia-Garcia HM, Justiz J, Pilgrim T, Wenaweser P, Meier B, Jüni P, Windecker S. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study. Int J Cardiol. 2014 May 1;173(2):259-67. PMID: 24631113.
  44. George I, Yerebakan H, Kalesan B, Nazif T, Kodali S, Smith CR, Williams MR. Age alone should not preclude surgery: contemporary outcomes after aortic valve replacement in nonagenarians. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1360-1369.e1. PMID: 24560419.
  45. Vranckx P, Kalesan B, Stefanini GG, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys PW, Windecker S. Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. EuroIntervention. 2015 Jun;11(2):171-9. PMID: 24531331.
  46. Simsek C, Räber L, Magro M, Boersma E, Onuma Y, Stefanini GG, Zanchin T, Kalesan B, Wenaweser P, Jüni P, van Geuns RJ, van Domburg RT, Windecker S, Serruys PW. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. Int J Cardiol. 2013 Dec 5;170(1):36-42. PMID: 24196314.
  47. Kalesan B, French C, Fagan JA, Fowler DL, Galea S. Firearm-related hospitalizations and in-hospital mortality in the United States, 2000-2010. Am J Epidemiol. 2014 Feb 1;179(3):303-12. PMID: 24148708.
  48. Radu MD, Räber L, Kalesan B, Muramatsu T, Kelbæk H, Heo J, Jørgensen E, Helqvist S, Farooq V, Brugaletta S, Garcia-Garcia HM, Jüni P, Saunamäki K, Windecker S, Serruys PW. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study. Eur Heart J. 2014 Mar;35(12):795-807. PMID: 24132187.
  49. O’Sullivan CJ, Stefanini GG, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab AA, Meier B, Wenaweser P, Jüni P, Windecker S. Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention. 2014 Jan 22;9(9):1076-84. PMID: 24064474.
  50. Taniwaki M, Räber L, Magro M, Kalesan B, Onuma Y, Stefanini GG, van Domburg RT, Moschovitis A, Meier B, Jüni P, Serruys PW, Windecker S. Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts. EuroIntervention. 2014;9(12):1432-40. PMID: 24064377.
  51. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. PMID: 23968698.
  52. Piazza N, Kalesan B, van Mieghem N, Head S, Wenaweser P, Carrel TP, Bleiziffer S, de Jaegere PP, Gahl B, Anderson RH, Kappetein AP, Lange R, Serruys PW, Windecker S, Jüni P. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 2013 May;6(5):443-51. PMID: 23702009.
  53. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013 Mar 21;368(12):1083-91. PMID: 23514285.
  54. Buellesfeld L, Stortecky S, Kalesan B, Gloekler S, Khattab AA, Nietlispach F, Delfine V, Huber C, Eberle B, Meier B, Wenaweser P, Windecker S. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2013 Jan;6(1):72-83. PMID: 23347864.
  55. Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini GG, Räber L, Meier B, Jüni P, Windecker S. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. EuroIntervention. 2013 Jan 22;8(9):1061-71. PMID: 23339812.
  56. Pilgrim T, Kalesan B, Wenaweser P, Huber C, Stortecky S, Buellesfeld L, Khattab AA, Eberle B, Gloekler S, Gsponer T, Meier B, Jüni P, Carrel T, Windecker S. Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis. Circ Cardiovasc Interv. 2012 Dec;5(6):856-61. PMID: 23169986.
  57. Shrestha NR, Kalesan B, Karki P, Sherpa K, Basnet A, Urban P, Pilgrim T. Rheumatic heart disease: pilot study for a population-based evaluation of prevalence and cardiovascular outcomes among schoolchildren in Nepal. BMJ Open. 2012 Oct 19;2(5). pii: e001616. PMID: 23087010.
  58. Räber L, Baumgartner S, Garcia-Garcia HM, Kalesan B, Justiz J, Pilgrim T, Moschovitis A, Khattab AA, Buellesfeld L, Wenaweser P, Meier B, Serruys PW, Jüni P, Windecker S. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study. JACC Cardiovasc Interv. 2012 Sep;5(9):946-57. PMID: 22995882.
  59. Osnabrugge RL, Head SJ, Genders TS, Van Mieghem NM, De Jaegere PP, van der Boon RM, Kerkvliet JM, Kalesan B, Bogers AJ, Kappetein AP, Hunink MG. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg. 2012 Dec;94(6):1954-60. PMID: 22959568.
  60. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012 Sep 13;367(11):991-1001. PMID: 22924638.
  61. Pilgrim T, Kalesan B, Karki P, Basnet A, Meier B, Urban P, Shrestha NR. Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in Nepal. BMJ Open. 2012 Jun 8;2(3). pii: e001320. PMID: 22685225.
  62. Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012 May;5(5):489-96. PMID: 22625186.
  63. Billinger M, Räber L, Hitz S, Stefanini GG, Pilgrim T, Stettler C, Zanchin T, Pulver C, Pfäffli N, Eberli F, Meier B, Kalesan B, Jüni P, Windecker S. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J. 2012 May;163(5):876-886.e2. PMID: 22607867.
  64. Pilgrim T, Vetterli F, Kalesan B, Stefanini GG, Räber L, Stortecky S, Gloekler S, Binder RK, Wenaweser P, Moschovitis A, Khattab AA, Buellesfeld L, Zwahlen M, Meier B, Jüni P, Windecker S. The impact of anemia on long-termclinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv. 2012 Apr;5(2):202-10. PMID: 22456025.
  65. Stefanini GG, Kalesan B, Pilgrim T, Räber L, Onuma Y, Silber S, Serruys PW, Meier B, Jüni P, Windecker S. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv. 2012 Mar;5(3):301-10. PMID: 22440496.
  66. Kalesan B, Pilgrim T, Heinimann K, Räber L, Stefanini GG, Valgimigli M, da Costa BR, Mach F, Lüscher TF, Meier B, Windecker S, Jüni P. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2012 Apr;33(8):977-87. PMID: 22362513.
  67. Kalesan B, Stefanini GG, Räber L, Schmutz M, Baumgartner S, Hitz S, Baldinger SH, Pilgrim T, Moschovitis A, Wenaweser P, Büllesfeld L, Khattab AA, Meier B, Jüni P, Windecker S. Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012 Feb;5(2):145-54. PMID: 22361598.
  68. Räber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, Jüni P, Serruys PW, Windecker S. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation. 2012 Mar 6;125(9):1110-21. PMID: 22302840.
  69. Cook S, Eshtehardi P, Kalesan B, Räber L, Wenaweser P, Togni M, Moschovitis A, Vogel R, Seiler C, Eberli FR, Lüscher T, Meier B, Jüni P, Windecker S. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J. 2012 Jun;33(11):1334-43. PMID: 22285579.
  70. Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012 Feb 14;125(6):803-12. PMID: 22238228.
  71. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, Khattab AA, Meuli F, Roth N, Eberle B, Erdös G, Brinks H, Kalesan B, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol. 2011 Nov 15;58(21):2151-62. PMID: 22078420.
  72. Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY,Eerdmans P, van Es GA, Meier B, Windecker S, Jüni P. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet. 2011 Dec 3;378(9807):1940-8. PMID: 22075451.
  73. McQueen A, Kreuter MW, Kalesan B, Alcaraz KI. Understanding narrative effects: the impact of breast cancer survivor stories on message processing, attitudes, and beliefs among African American women. Health Psychol. 2011 Nov;30(6):674-82. PMID: 21895370.
  74. Klauss V, Serruys PW, Pilgrim T, Buszman P, Linke A, Ischinger T, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, van Geuns RJ, van Es GA, Kalesan B, Wenaweser P, Jüni P, Windecker S. 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice. JACC Cardiovasc Interv. 2011 Aug;4(8):887-95. PMID: 21851904.
  75. Räber L, Wohlwend L, Wigger M, Togni M, Wandel S, Wenaweser P, Cook S, Moschovitis A, Vogel R, Kalesan B, Seiler C, Eberli F, Lüscher TF, Meier B, Jüni P, Windecker S. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation. 2011 Jun 21;123(24):2819-28, 6 p following 2828. PMID: 21646500.
  76. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Büllesfeld L, Khattab AA, Huber C, Eberle B, Erdös G, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011 Jun;161(6):1114-24. PMID: 21641358.
  77. Räber L, Jüni P, Nüesch E, Kalesan B, Wenaweser P, Moschovitis A, Khattab AA, Bahlo M, Togni M, Cook S, Vogel R, Seiler C, Meier B, Windecker S. Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization. J Am Coll Cardiol. 2011 May 24;57(21):2143-51. PMID: 21596229.
  78. Jeng CL, Baumbach SF, Campbell J, Kalesan B, Myerson MS. Comparison of initial compression of the medial, lateral, and posterior screws in an ankle fusion construct. Foot Ankle Int. 2011 Jan;32(1):71-6. PMID: 21288437.
  79. Kreuter MW, Holmes K, Alcaraz K, Kalesan B, Rath S, Richert M, McQueen A, Caito N, Robinson L, Clark EM. Comparing narrative and informational videos to increase mammography in low-income African American women. Patient Educ Couns. 2010 Dec;81 Suppl:S6-14. PMID: 21071167.
  80. Thompson VL, Kalesan B, Wells A, Williams SL, Caito NM. Comparing the use of evidence and culture in targeted colorectal cancer communication for African Americans. Patient Educ Couns. 2010 Dec;81 Suppl:S22-33. PMID: 20702056.
  81. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009 Jun;18(2):148-58. PMID: 19645960.
  82. Sealey RJ, Myerson MS, Molloy A, Gamba C, Jeng C, Kalesan B. Sagittal plane motion of the hindfoot following ankle arthrodesis: a prospective analysis. Foot Ankle Int. 2009 Mar;30(3):187-96. PMID: 19321094.
  83. Gallicchio L, Kalesan B, Hoffman SC, Helzlsouer KJ. Non-cancer adverse health conditions and perceived health and function among cancer survivors participating in a community-based cohort study in Washington County, Maryland. J Cancer Surviv. 2008 Mar;2(1):12-9. PMID: 18648983.
  84. Gallicchio L, Kalesan B, Huang HY, Strickland P, Hoffman SC, Helzlsouer KJ. Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in Washington county, Maryland. PPAR Res. 2008; 2008:276581. PMID: 18288282.
  85. Schkrohowsky JG, Kalesan B, Alberg AJ. Tobacco awareness in three U.S. medical schools. J Addict Dis. 2007;26(3):101-6. PMID: 18018813.
  86. Kalesan B, Stine J, Alberg AJ. The joint influence of parental modeling and positive parental concern on cigarette smoking in middle and high school students. J Sch Health. 2006 Oct; 76(8):402-7; quiz 438-9. PMID: 16978163.